Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary

Histopathology

Volumn 63, Issue 4, 2013, Pages 534-544

  Halimi, Sultan Ahmad ^a   Maeda, Daichi ^a   Shinozaki Ushiku, Aya ^a   Koso, Takahiro ^a   Matsusaka, Keisuke ^a   Tanaka, Mariko ^a   Arimoto, Takahide ^a   Oda, Katsutoshi ^a   Kawana, Kei ^a   Yano, Tetsu ^a   Fujii, Tomoyuki ^a   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Claudin 18; Mucinous borderline tumour; Ovary

Indexed keywords

CA 125 ANTIGEN; CLAUDIN 18; CYTOKERATIN 20; CYTOKERATIN 7; ESTROGEN RECEPTOR; MUCIN 1; MUCIN 2; MUCIN 5AC; MUCIN 6; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR CDX2; VIMENTIN;

ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCERVICAL LIKE MUCINOUS BORDERLINE TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUELLERIAN DUCT; OVARIAN INTESTINAL TYPE MUCINOUS BORDERLINE TUMOR; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROUS BORDERLINE TUMOR;

CLAUDIN-18; MUCINOUS BORDERLINE TUMOUR; OVARY;

CLAUDINS; CLUSTER ANALYSIS; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOMA, MUCINOUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884722478     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12182     Document Type: Article

References (36)

1. Tavassoli FA, Devilee P, eds. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003; 124-129.
2. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int. J. Gynecol. Pathol. 2006; 25; 83-89.
3. Yasunaga M, Ohishi Y, Oda Y et al. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors. Hum. Pathol. 2009; 40; 965-974.
4. Nakatsuka S, Wakimoto T, Ozaki K et al. Mucinous borderline-like tumor of the gastrointestinal type arising from mature cystic teratoma of the ovary and its immunohistochemical cytokeratin and mucin phenotype. J. Obstet. Gynaecol. Res. 2012; 38; 471-475.
5. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod. Pathol. 2006; 19; 97-105.
6. Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am. J. Surg. Pathol. 2002; 26; 1529-1541.
7. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am. J. Clin. Pathol. 2005; 123(Suppl); S13-S57.
8. Wu CH, Mao TL, Vang R et al. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of arid1a. Int. J. Gynecol. Pathol. 2012; 31; 297-303.
9. Nomura K, Aizawa S. Clinicopathologic and mucin histochemical analyses of 90 cases of ovarian mucinous borderline tumors of intestinal and Müllerian types. Pathol. Int. 1996; 46; 575-580.
10. Hart WR. Borderline epithelial tumors of the ovary. Mod. Pathol. 2005; 18(Suppl 2); S33-S50.
11. Moriya T, Mikami Y, Sakamoto K et al. Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findings. Med. Electron Microsc. 2003; 36; 240-246.
12. Vang R, Gown AM, Zhao C et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am. J. Surg. Pathol. 2007; 31; 854-869.
13. Boman F, Buisine MP, Wacrenier A, Querleu D, Aubert JP, Porchet N. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study. J. Pathol. 2001; 193; 339-344.
14. Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM. Cytokeratins 7 and 20, DPC4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: DPC4 assists in identifying metastatic pancreatic carcinomas. Int. J. Gynecol. Pathol. 2002; 21; 391-400.
15. Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer 1988; 61; 546-554.
16. Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 1988; 61; 340-348.
17. Siriaunkgul S, Robbins KM, McGowan L, Silverberg SG. Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and Müllerian type. Int. J. Gynecol. Pathol. 1995; 14; 198-208.
18. Rodriguez IM, Irving JA, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am. J. Surg. Pathol. 2004; 28; 1311-1318.
19. Fukunaga M, Ushigome S. Epithelial metaplastic changes in ovarian endometriosis. Mod. Pathol. 1998; 11; 784-788.
20. Mineta K, Yamamoto Y, Yamazaki Y et al. Predicted expansion of the claudin multigene family. FEBS Lett. 2011; 585; 606-612.
21. Tsukita S, Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J. Cell Biol. 2000; 149; 13-16.
22. Tamura A, Yamazaki Y, Hayashi D et al. Claudin-based paracellular proton barrier in the stomach. Ann. NY Acad. Sci. 2012; 1258; 108-114.
23. Shinozaki A, Ushiku T, Morikawa T et al. Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling. J. Histochem. Cytochem. 2009; 57; 775-785.
24. Shinozaki A, Shibahara J, Noda N et al. Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch. 2011; 459; 73-80.
25. Tanaka M, Shibahara J, Fukushima N et al. Claudin-18 is an early-stage marker of pancreatic carcinogenesis. J. Histochem. Cytochem. 2011; 59; 942-952.
26. Matsuda M, Sentani K, Noguchi T et al. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis. Pathol. Int. 2010; 60; 673-680.
27. Sahin U, Koslowski M, Dhaene K et al. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin. Cancer Res. 2008; 14; 7624-7634.
28. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006; 6; 186.
29. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J. Pathol. 2006; 208; 633-642.
30. Ricardo S, Gerhard R, Cameselle-Teijeiro JF, Schmitt F, Paredes J. Claudin expression in breast cancer: high or low, what to expect? Histol. Histopathol. 2012; 27; 1283-1295.
31. Sentani K, Oue N, Tashiro T et al. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am. J. Surg. Pathol. 2008; 32; 1182-1189.
32. Hayashi D, Tamura A, Tanaka H et al. Deficiency of claudin-18 causes paracellular h+ leakage, up-regulation of interleukin-1β, and atrophic gastritis in mice. Gastroenterology 2012; 142; 292-304.
33. Baker AC, Eltoum I, Curry RO et al. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix. Arch. Pathol. Lab. Med. 2006; 130; 1510-1515.
34. Ota H, Harada O, Uehara T, Hayama M, Ishii K. Aberrant expression of TFF1, TFF2, and PDX1 and their diagnostic value in lobular endocervical glandular hyperplasia. Am. J. Clin. Pathol. 2011; 135; 253-261.
35. Hirabayashi K, Yasuda M, Kajiwara H et al. Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of mUC2, MUC5AC, MUC6, and CD10 expression. Acta Histochem. Cytochem. 2008; 41; 15-21.
36. Vang R, Gown AM, Wu LS et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod. Pathol. 2006; 19; 1421-1428.